78 related articles for article (PubMed ID: 1955538)
1. Preponderance of basic isoforms of serum luteinizing hormone (LH) is associated with the high bio/immune ratio of LH in healthy women and in women with polycystic ovarian disease.
Ding YQ; Huhtaniemi I
Hum Reprod; 1991 Mar; 6(3):346-50. PubMed ID: 1955538
[TBL] [Abstract][Full Text] [Related]
2. Neither exogenous nor endogenous GnRH stimulation alters the bio/immuno ratio of serum LH in healthy women and in polycystic ovarian disease.
Ding YQ; Anttila L; Ruutiainen K; Erkkola R; Irjala K; Huhtaniemi I
Acta Obstet Gynecol Scand; 1991; 70(3):211-7. PubMed ID: 1927298
[TBL] [Abstract][Full Text] [Related]
3. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
4. A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome.
Ropelato MG; Garcia-Rudaz MC; Castro-Fernandez C; Ulloa-Aguirre A; Escobar ME; Barontini M; Veldhuis JD
J Clin Endocrinol Metab; 1999 Dec; 84(12):4629-36. PubMed ID: 10599730
[TBL] [Abstract][Full Text] [Related]
5. Less acidic forms of luteinizing hormone are associated with lower testosterone secretion in men on haemodialysis treatment.
Mitchell R; Bauerfeld C; Schaefer F; Schärer K; Robertson WR
Clin Endocrinol (Oxf); 1994 Jul; 41(1):65-73. PubMed ID: 8050133
[TBL] [Abstract][Full Text] [Related]
6. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.
Waldstreicher J; Santoro NF; Hall JE; Filicori M; Crowley WF
J Clin Endocrinol Metab; 1988 Jan; 66(1):165-72. PubMed ID: 2961784
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea.
Burger CW; Korsen T; van Kessel H; van Dop PA; Caron FJ; Schoemaker J
J Clin Endocrinol Metab; 1985 Dec; 61(6):1126-32. PubMed ID: 3932449
[TBL] [Abstract][Full Text] [Related]
8. The bio/immuno ratio of serum luteinizing hormone increases after orchiectomy in prostatic cancer patients and is associated with decreased molecular weight and appearance of isohormones with alkaline pI values.
Haavisto AM; Simberg N; Huhtaniemi I
Biol Reprod; 1990 Apr; 42(4):597-602. PubMed ID: 2346770
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
10. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
[TBL] [Abstract][Full Text] [Related]
11. More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase.
Wide L; Bakos O
J Clin Endocrinol Metab; 1993 Apr; 76(4):885-9. PubMed ID: 8473400
[TBL] [Abstract][Full Text] [Related]
12. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
13. Effects of luteinizing hormone releasing hormone (LHRH) upon bioactive and immunoreactive serum LH levels in normal subjects.
Dufau ML; Beitins IZ; McArthur JW; Catt KJ
J Clin Endocrinol Metab; 1976 Sep; 43(3):658-67. PubMed ID: 783183
[TBL] [Abstract][Full Text] [Related]
14. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
Zaidi J; Jacobs H; Campbell S; Tan SL
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
[TBL] [Abstract][Full Text] [Related]
15. Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays.
Imse V; Holzapfel G; Hinney B; Kuhn W; Wuttke W
J Clin Endocrinol Metab; 1992 May; 74(5):1053-61. PubMed ID: 1569153
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha versus LH and androstendione as a reliable predictor of spontaneous ovulation after laparoscopic ovarian drilling for women with clomiphene citrate resistance polycystic ovarian disease.
Seyam E; Hefzy E
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():126-133. PubMed ID: 29408743
[TBL] [Abstract][Full Text] [Related]
18. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
Li Y; Wei LN; Xiong YL; Liang XY
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
[TBL] [Abstract][Full Text] [Related]
19. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.
Spinder T; Spijkstra JJ; van den Tweel JG; Burger CW; van Kessel H; Hompes PG; Gooren LJ
J Clin Endocrinol Metab; 1989 Jul; 69(1):151-7. PubMed ID: 2471710
[TBL] [Abstract][Full Text] [Related]
20. Pituitary luteinizing hormone microheterogeneity in the afternoon of proestrus in rats: some new insights.
De Biasi SN; Pérez GT; Apfelbaum LI; Apfelbaum ME
Horm Res; 2002; 58(1):8-15. PubMed ID: 12169775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
